JP2024524388A5 - - Google Patents

Info

Publication number
JP2024524388A5
JP2024524388A5 JP2023580537A JP2023580537A JP2024524388A5 JP 2024524388 A5 JP2024524388 A5 JP 2024524388A5 JP 2023580537 A JP2023580537 A JP 2023580537A JP 2023580537 A JP2023580537 A JP 2023580537A JP 2024524388 A5 JP2024524388 A5 JP 2024524388A5
Authority
JP
Japan
Prior art keywords
seq
complement
position corresponding
adenine
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023580537A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524388A6 (ja
JP2024524388A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035846 external-priority patent/WO2023278787A2/en
Publication of JP2024524388A publication Critical patent/JP2024524388A/ja
Publication of JP2024524388A5 publication Critical patent/JP2024524388A5/ja
Publication of JP2024524388A6 publication Critical patent/JP2024524388A6/ja
Pending legal-status Critical Current

Links

JP2023580537A 2021-07-02 2022-06-30 Ｗｎｔファミリーメンバー５Ｂ（ＷＮＴ５Ｂ）阻害剤での低下した骨塩密度の処置 Pending JP2024524388A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163218209P 2021-07-02 2021-07-02
US63/218,209 2021-07-02
PCT/US2022/035846 WO2023278787A2 (en) 2021-07-02 2022-06-30 Treatment of decreased bone mineral density with wnt family member 5b (wnt5b) inhibitors

Publications (3)

Publication Number Publication Date
JP2024524388A JP2024524388A (ja) 2024-07-05
JP2024524388A5 true JP2024524388A5 (https=) 2025-07-07
JP2024524388A6 JP2024524388A6 (ja) 2025-08-08

Family

ID=82839088

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580537A Pending JP2024524388A (ja) 2021-07-02 2022-06-30 Ｗｎｔファミリーメンバー５Ｂ（ＷＮＴ５Ｂ）阻害剤での低下した骨塩密度の処置

Country Status (10)

Country Link
US (1) US20230083558A1 (https=)
EP (1) EP4363586A2 (https=)
JP (1) JP2024524388A (https=)
KR (1) KR20240043753A (https=)
CN (1) CN117940565A (https=)
AU (1) AU2022302084A1 (https=)
CA (1) CA3225083A1 (https=)
IL (1) IL309644A (https=)
MX (1) MX2023015271A (https=)
WO (1) WO2023278787A2 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090047276A1 (en) * 2007-05-15 2009-02-19 University Of Washington Methods for increasing cell or tissue regeneration in a vertebrate subject
WO2017023973A1 (en) * 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-indol-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

Similar Documents

Publication Publication Date Title
Burke et al. Synergistic expression of the CXCL10 gene in response to IL-1β and IFN-γ involves NF-κB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4
TWI351953B (en) Use,pharmaceutical composition and combination of
Shi et al. Gene expression profiling in the developing rat brain exposed to ketamine
Li et al. TWIST1 associates with NF-κ B subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production
ES2632212T3 (es) miR-135 y composiciones que lo comprenden para el tratamiento de afecciones médicas asociadas con la serotonina
JP2009521934A (ja) 薬物標的としての天然アンチセンスおよび非コードｒｎａ転写物
JP2017506228A (ja) セロトニン放出ホルモン、アドレナリン放出ホルモン、ノルアドレナリン放出ホルモン、グルタミン酸放出ホルモンおよび副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのマイクロｒｎａおよび該マイクロｒｎａを含む組成物
Sun et al. TRPM2-mediated feed-forward loop promotes chondrocyte damage in osteoarthritis via calcium-cGAS-STING-NF-κB pathway
Cao et al. Hoxa5 promotes adipose differentiation via increasing DNA methylation level and inhibiting PKA/HSL signal pathway in mice
Yin et al. CircRNA hsa_circ_0006859 inhibits the osteogenic differentiation of BMSCs and aggravates osteoporosis by targeting miR-642b-5p/miR-483-3p and upregulating EFNA2/DOCK3
JP2002525081A (ja) 低酸素により調節される遺伝子転写に特徴的な配列
Kitamura et al. Interferon-α exerts proinflammatory properties in experimental radiation-induced esophagitis: possible involvement of plasmacytoid dendritic cells
Zhang et al. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk‐JNK Through DOK3
JP2024524388A5 (https=)
JP2024524375A5 (https=)
Kim et al. Dexamethasone differentially regulates renal and duodenal calcium‐processing genes in calbindin‐D9k and‐D28k knockout mice
Wang et al. KLF14 inhibits tumor progression via FOSL1 in glioma
JP2024528284A5 (https=)
US12509687B2 (en) Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
JP2009516710A (ja) ｅＩＦ４Ｅ−ＢＰ２の発現のモジュレート
KR20080106415A (ko) 유전자 발현을 조절하기 위한 조성물의 제조에서 ｄｈａ 및ａｒａ의 용도
US20160101111A1 (en) Combined inhibition of the vitamin d receptor and poly(adp) ribose polymerase (parp) in the treatment of cancer
Xie et al. Identification of XD23 as a potent inhibitor of osteosarcoma via downregulation of DKK1 and activation of the WNT/β-catenin pathway
Chen et al. UBE2N modulates osteoclast differentiation via BTK-PLCγ2-Ca2+ signaling pathway to promote osteoporosis
US20240254489A1 (en) Compositions and methods of targeting the pax6 signaling pathway to reduce formation of amyloid beta plaques and neurofibrillary tangles